Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P C W HogendoornPathology and Biology Subcommittee of the EORTC Soft Tissue and Bone Sarcoma Group

Abstract

Though soft tissue sarcomas are rare considerable progress has been made in the clinical and biological understanding of these neoplasms. This has led to the launch of a new WHO classification of soft tissue tumours in 2002, which integrate morphological data with tumour specific (cyto-) genetics. Moreover worldwide consensus has grown how to predict clinical behaviour based on a specific grading system and which specific types of tumours seem not to obey these rules. As a consequence entry criteria for multi-institute prospective trials have changed over the last few years. The recent identification of tumour specific drug targets by immunohistochemistry has had impact on specimen requirements and handling as well as laboratory standards. These changes in concepts, classification, and processing of soft tissue sarcomas have had impact on patient selection and treatment and formats of multi-institute trials.

References

Jan 15, 1984·International Journal of Cancer. Journal International Du Cancer·M TrojaniC Lagarde
Dec 1, 1996·Human Pathology·S R GranterA E Rosenberg
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Dec 22, 1999·Journal of Clinical Pathology·J F Graadt van RoggenP C Hogendoorn
Jul 15, 2000·The American Journal of Surgical Pathology·M WernerH Battifora
Sep 28, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·S KumarM Tsokos
Feb 24, 2001·Journal of Clinical Pathology·J F Graadt van RoggenP C Hogendoorn
Jul 28, 2001·The American Journal of Surgical Pathology·A L FolpeS W Weiss
Dec 18, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·S E KilpatrickG D Bos
Feb 28, 2002·American Journal of Clinical Pathology·Jason L Hornick, Christopher D M Fletcher
Jul 12, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C GourleyH Gabra
Nov 5, 2002·The American Journal of Pathology·Matt van de Rijn, Brian P Rubin
Mar 18, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jean-Michel CoindreAlain Aurias
Jun 26, 2003·Histopathology·J M Coindre
Apr 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J K AnningaP C W Hogendoorn

❮ Previous
Next ❯

Citations

Sep 30, 2009·Virchows Archiv : an International Journal of Pathology·Judith V M G Bovée, Pancras C W Hogendoorn
Feb 19, 2010·Virchows Archiv : an International Journal of Pathology·Louis GuillouFred T Bosman
Dec 4, 2012·Indian Journal of Surgical Oncology·A S AljababK A Pathak
Dec 4, 2012·Indian Journal of Surgical Oncology·Nuzhat Husain, Nidhi Verma
Dec 12, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A SantoroA Bertuzzi
Jun 25, 2008·American Journal of Clinical Dermatology·Hans-Georg KoppJörg Thomas Hartmann
Mar 3, 2011·Journal of Biomedical Optics·Esteban F CarbajalKirill V Larin
Aug 14, 2008·Expert Review of Anticancer Therapy·Alexander D Rapidis
Jun 7, 2008·Expert Review of Anticancer Therapy·Radha Todd, John Lunec
Nov 30, 2011·Seminars in Oncology·Elizabeth G Demicco, Alexander J Lazar
Oct 16, 2010·Oral Oncology·Remco de BreeC René Leemans
Oct 27, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefan SleijferJean-Yves Blay
Nov 11, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael LeahyUNKNOWN European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Mar 4, 2008·International Journal of Cancer. Journal International Du Cancer·Jennie N JeyapalanNicola J Royle
Jan 6, 2015·Journal of Surgical Oncology·Karen De Amorim Bernstein, Thomas F Delaney
Sep 5, 2006·Critical Reviews in Oncology/hematology·Sebastian Bauer, Joerg T Hartmann
Nov 29, 2005·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·F CollinJ M Coindre
Aug 10, 2018·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Javal ShethGino R Somers
May 8, 2018·The Journal of Hand Surgery Asian-Pacific Volume·Joon Yub KimJae Ho Cho
Aug 29, 2014·Einstein·Mario LenzaMario Ferretti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.